The use of a “gray zone” considering measurement uncertainty in pharmacological tests. The serum growth hormone stimulation test as an example

Articles in the same Issue

1. Frontmatter
2. Editorials
3. CCLM Award for the Most Cited Paper Recently Published
4. Laboratory economics. Risk or opportunity?
5. Reviews
6. Molecular diagnosis and precision medicine in allergy management
7. The insulin autoimmune syndrome (IAS) as a cause of hypoglycaemia: an update on the pathophysiology, biochemical investigations and diagnosis
8. Opinion Paper
9. Role of microsatellite instability, immunohistochemistry and mismatch repair germline aberrations in immunosuppressed transplant patients: a phenocopy dilemma in Muir-Torre syndrome
10. Genetics and Molecular Diagnostics
11. Time and tumor type (primary or metastatic) do not influence the detection of BRAF/NRAS mutations in formalin fixed paraffin embedded samples from melanomas
12. False low holotranscobalamin levels in a patient with a novel TCN2 mutation
13. General Clinical Chemistry and Laboratory Medicine
14. Quality performance of laboratory testing in pharmacies: a collaborative evaluation
15. Cost evaluation of clinical laboratory in Taiwan’s National Health System by using activity-based costing
16. Impact of sample processing on the measurement of circulating microparticles: storage and centrifugation parameters
17. HbA_1c: EQA in Germany, Belgium and the Netherlands using fresh whole blood samples with target values assigned with the IFCC reference system
18. Iohexol clearance in unstable critically ill patients: a tool to assess glomerular filtration rate
19. Characteristics of Chinese patients with antiphospholipid syndrome and the ability of lupus anticoagulant assays to identify them
20. Reference Values and Biological Variations
21. Distribution of soluble suppression of tumorigenicity 2 (sST2), N-terminal pro-brain natriuretic peptide (NT-proBNP), high sensitive troponin I and high-sensitive troponin T in umbilical cord blood
22. Hematology and Coagulation
23. Evaluation of Mindray BC-6800 body fluid mode for automated cerebrospinal fluid cell counting
24. Cancer Diagnostics
25. Increased sialylation and reduced fucosylation of exfoliated cervical cells are potential markers of carcinogenesis in the cervix
26. Cardiovascular Diseases
27. High incidence of macrotroponin I with a high-sensitivity troponin I assay
28. Infectious Diseases
29. Prospective evaluation of biomarkers for prediction of quality of life in community-acquired pneumonia
30. Letter to the Editor
31. The use of extra-analytical phase quality indicators by clinical laboratories: the results of an international survey
32. Quality of reporting of diagnostic test accuracy studies in medical laboratory journals
33. Impact of under-filled blood collection tubes containing K₂EDTA and K₃EDTA as anticoagulants on automated complete blood count (CBC) testing
34. Stability of plasma albumin depends on measurement method
35. Evaluation of screening method for Bence Jones protein analysis
36. Reference intervals for the Kryptor second-generation chromogranin A assay
37. Evaluation of an automated urinary iodine measurement using AU5800 analyzer with AutoLab Iodine reagent
38. Evaluation of the accuracy of complete blood count for insufficient blood samples
39. The use of a “gray zone” considering measurement uncertainty in pharmacological tests. The serum growth hormone stimulation test as an example
40. Keeping Ebola out of the lab: a practical solution on how to analyze Ebola associated blood anomalies
41. Standardized fixation process is crucial to permit molecular analyses in formalin-fixed and paraffin-embedded melanoma samples
42. Congress Abstracts
43. 48th National Congress of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology (SIBioC – Laboratory Medicine)
44. 8^th Santorini Conference Systems Medicine and Personalised Health and Therapy
45. Congress of Laboratory Medicine and Clinical Chemistry